PEABODY, Mass., Nov. 27, 2016 -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced that it will introduce bkFusion1, a groundbreaking solution for improving biopsy targeting in prostate cancer, at the 102nd Annual Meeting of the Radiological Society of North America (RSNA). bkFusion is the latest innovation from the company’s flagship BK Ultrasound brand. It is the first MR-fusion biopsy application, fully integrated into BK Ultrasound’s bk3000 premium ultrasound system designed uniquely for use by urologists for both hospital and office settings.
Targeting subtle prostate lesions for biopsy is difficult with ultrasound alone. bkFusion seamlessly overlays MR image information about lesion location and extent onto real-time ultrasound images, without the need for an additional workstation. This improves workflow and minimizes the system’s footprint, which are significant benefits for the urologist performing biopsies in the office, enabling faster and more reliable disease management.
BK Ultrasound, powered by Analogic, has partnered with MIM Software Inc., a provider of market-leading imaging solutions for radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging, to create bkFusion. The innovative software builds on MIM’s unique Predictive Fusion technology to enable the urologist to precisely biopsy MR-defined targets in less time and with more accuracy than a traditional ultrasound-only biopsy approach. With its small footprint, the bk3000 fits easily into any office space and because bkFusion is completely integrated on the ultrasound system, no additional bulky equipment or set-up time is required. The system communicates easily with radiology departments, accessing the MR images via PACS or a secure cloud platform.
“We are very pleased to launch a ground-breaking new solution for the Urology community in partnership with MIM” said Jacques Coumans PhD, VP, chief marketing & scientific officer. “Our customers are our best guide for break-through innovation. Complementing MIM’s leadership in medical image processing for cancer visualization with our strength in specialty ultrasound has created a solution our customers have been looking for. Current solutions for MR-fusion have had MR at the center of the workflow. With bkFusion, we put real-time ultrasound as the focus of our Urology-centered approach. The MR information helps point urologists more precisely to their target, and the prostate image quality provided by the bk3000 helps urologists visualize and revalidate subtle lesions.”
“We are excited to partner with BK Ultrasound to bring this innovative application to Urology,” said, Jon Piper, VP of R&D from MIM. “bkFusion makes it possible to harness the power of MR imaging in the Urology office, providing patients with the clinical benefits of a more targeted biopsy in the privacy and comfort of their physician’s practice setting. Our approach has always been to focus on technology that benefits the greatest number of patients possible by being practical for use in centers of any size.”
Analogic will also showcase its newest innovative products that deliver to OEMs breakthrough reliability and lowest cost of ownership in their CT, MRI, and digital mammography offerings. Featured products will include its 64-slice, 85-cm bore CT gantry, equipped with LISA (Low Dose Imaging Software by Analogic); its latest 1.5T RF amplifier for MRI; and its newest Selenium-based, direct-digital detector for mammography.
Visit Analogic at Booth #6124 during RSNA 2016. More information may be found at www.analogic.com.
About Analogic
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging and real-time guidance technologies used for disease diagnosis and treatment as well as for automated threat detection. Our market-leading ultrasound systems, led by our flagship BK Ultrasound brand, used in procedure-driven markets such as urology, surgery, and point-of-care, are sold to clinical practitioners around the world. Our advanced imaging technologies are also used in computed tomography (CT), magnetic resonance imaging (MRI) and digital mammography systems, as well as automated threat detection systems for aviation security. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.
1 Expected availability in early 2017.
Analogic and the globe logo are registered trademarks, and BK Ultrasound and bkFusion are trademarks, of Analogic Corporation or its affiliated companies.
For further information, please contact:
Investor Contact:
Mark Namaroff
Director of Investor Relations
(978) 326-4058
[email protected]
Media Contact:
Judith Rossi
Sr. Director, Marketing Communications
(978) 317-5172
[email protected]


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



